US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
To-be Listed
Name
/
Code
Industry Offer Price Lot Size Entry Fee Closing Date
Grey Market Date
Listing Date
Minieye Tec
02431.HK
Application Software 17-20.2 200 4,081 2024/12/20 2024/12/24 2024/12/27
Xunfei Healthcare
02506.HK
Application Software 82.8 50 N/A 2024/12/23 2024/12/27 2024/12/30
InnoScience
02577.HK
Semiconductors & Semiconductor Equipment 30.86-33.66 100 3,400 2024/12/23 2024/12/27 2024/12/30
HealthyWay
02587.HK
Health Care Services 7.8-8.8 500 4,444 2024/12/23 2024/12/27 2024/12/30
Summary
We are an AI-empowered healthcare solution provider. Our products and solutions cover the full healthcare service cycle, ranging from health risk warnings, early screening, diagnosis, treatment and treatment effect evaluation to post-discharge management and chronic disease management. We have independently developed AI technologies that underpin our products and solutions. Specifically, we offer (i) Primary Health Care (“PHC”) Services to assist PHC doctors in improving their service capabilities and enable more effective monitoring by regional healthcare administrators; (ii) Hospital Services to improve the operational efficiency of hospitals and doctors; (iii) Patient Services to enhance the convenience and quality of healthcare services that patients and residents receive; and (iv) Regional Healthcare Solutions to assist regional healthcare administrators in data-driven integrated management as well as efficient deployment of health insurance funds. We ranked first in the healthcare AI industry in terms of revenue in China with a market share of 5.9% in 2023, according to Frost & Sullivan. iFlytek, a leading AI company focused on research of core AI technology, is our Controlling Shareholder.

Our Products and Solutions

Our healthcare AI solution matrix caters to the diverse needs of all major stakeholders in the healthcare industry, extending our reach from PHC institutions to hospitals, patients and residents, as well as regional healthcare administrators. Our products and solutions cover the full healthcare service cycle, ranging from health risk warnings, early screening, diagnosis, treatment and treatment effect evaluation to post-discharge management and chronic disease management. Many of our products and solutions are underpinned by the same core technologies, such as natural language processing (“NLP”) models, medical knowledge graphs, speech recognition, knowledge-based medical reasoning, but are offered to different target users in distinct application scenarios. We generate revenue from both project implementation on project basis and from continual provision of products and services, namely maintenance and operation services, AI outbound callings, patient service package, cloud medical imaging and medical device. The duration of our projects ranges from one to five years, during which we provide maintenance and other services free of charge. Upon expiration of the warranty period, we charge fees for maintenance and operation services. In particular:

‧ PHC Services. Our PHC Services business line consists of General Practice Clinical Decision Support System (“CDSS”), and Chronic Disease Management Tools. Our General Practice CDSS provides medical recommendations including diagnosis suggestions, test and examination suggestions as well as medication examinations and auxiliary support such as generation and quality control of electric medical records (“EMRs”) to doctors at PHC institutions. Our General Practice CDSS help enhance clinical skills, improve the ability to assess medication appropriateness and standardize the diagnosis and treatment process for doctors at PHC institutions, thereby reducing medical errors. It also offers monitoring services for regional healthcare administrators such as provincial-level health commissions, enabling evidence-based quality control and precise management. Our Chronic Disease Management Tools allow patients to upload data, view results and receive timely alerts for irregular conditions and enable doctors to collect information, decide on interventions and use automated reminder systems. These tools establish a tiered management model for chronic diseases such as hypertension and hyperglycemia and streamline chronic disease management for health commissions and PHC institutions.

‧ Hospital Services. Our Hospital Services business line encompasses Smart Hospital Solutions and Intelligent Assistant. Our Smart Hospital Solutions offer (i) intelligent patient triage system and medical history collection services to patients at the pre-diagnosis phase; (ii) intelligent virtual assistant that helps patients manage the entire treatment process, and doctor-facing mobile workstation namely, iDoctor and the speech-to-text EMR generation tools for the efficiency and convenience of doctors at the during-diagnosis phase; and (iii) an array of AI-empowered tools to address the pain points doctors and medical professionals commonly face when conducting patient follow-ups. Our solutions also help hospital management’s decision-making by providing statistical analysis of operational data. Our Smart Hospital Solutions are developed to improve the efficiency and medical service quality of doctors in the area of patient management. Our Intelligent Assistant facilitates hospitals in enhancing overall efficiency and the medical service quality of doctors with functionality such as General Practice and Specialized CDSS Tools and AI EMR Quality Control.

‧ Patient Services. Our Patient Services business line includes Post-discharge Management Platform (including our Xunfei Xiaoyi App and Mini Program), Cloud Medical Imaging Platform and Medical Device. Our Post-Discharge Management Platform is developed to customize patient management planning post discharge allowing patients to connect and communicate with their doctors on this platform, upload medical history after hospital discharge, receive medication reminders and conduct self-reports and enabling doctors to gather and analyze data in relation to patient recovery or change of conditions. Our Cloud Medical Imaging Platform is designed to provide remote medical imaging services that allow medical institutions to remotely retrieve medical imaging data from other medical institutions that have been granted shared access, and aid the implementation of a tiered diagnosis and treatment system. Our Medical Device primarily consists of hearing aids. In October 2023, we launched a patient-oriented application empowered by Xunfei Spark Medical Model, Xunfei Xiaoyi App and Mini Program, to meet the needs of patients and residents across the pre-visit, consultation or treatment and post-discharge phases. It provides pre-visit enquiry function and supports medication planning, interpretation of medical and health check examination reports, health reminders based on such reports and identification of the correct department for subsequent follow-up visits.

‧ Regional Healthcare Solutions. Our Regional Healthcare Solutions business line consists of Regional Healthcare Administrator Services and Medical Insurance Administrative Solutions. Our Regional Healthcare Administrator Services are designed to promote integrated healthcare administration, covering outpatient services, inpatient services and public health services. Our Medical Insurance Administrative Solutions allow us to expand our customer base from healthcare service providers to healthcare payors. Regional medical security bureaus, PHC institutions and hospitals can use our data-driven solutions to examine and analyze the reasonableness of insurance claims.



Source: Xunfei Healthcare (02506) Prospectus (IPO Date : 2024/12/18)
Listing Market MAIN
Industry Application Software
Background H Shares
Major Business Area China
Corporate Information
Substantial Shareholders iFlytek Co., Ltd. (49.42%)
Lu Xiaoliang (16.11%)
Xu Jingming (15.47%)
Directors Liu Qingfeng (Chairman and Non-Executive Director)
Tao Xiaodong (General Manager and Executive Director)
Duan Dawei (Non-Executive Director)
Zhao Zhiwei (Non-Executive Director)
Tan Ching (Independent Non-Executive Director)
Wang Yang (Independent Non-Executive Director)
Zhao Huifang (Independent Non-Executive Director)
Company Secretary Liu Wei
Yeung Siu Lam
Principal Bankers China Merchants Bank
Huishang Bank
Solicitors Clifford Chance
CM Law Firm
Pillsbury Winthrop Shaw Pittman LLP
Auditors Deloitte Touche Tohmatsu
Registered Office 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong
Share Registrars Tricor Investor Services Ltd. [Tel: (852) 2980-1333]
Share Registrars Tel No (852) 2980-1333
Internet Address http://www.iflyhealth.com
Email Address
Tel No
Fax No
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security or any other trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the said information, commentaries and/or buy/sell ratings on this app/website are taken at your own risk for your own account.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 6 January 2023.